Sort
51,593 grants matching “hepatitis”
Strategies for Cancer Immunotherapy Clinical Trials
$639,565Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Alpha-Particle Emitter Radiopharmaceutical Therapy for Liver Cancer
$639,549Jessie Nedrow · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Hepatitis C Pathogenesis and the Human Genome
$639,491David L Thomas · Johns Hopkins University · R01 · FY2013 · DA
Adiponectin in Cardiovascular Biology and Pathology
$639,475Harvey F Lodish · Massachusetts Institute Of Technology · P01 · FY2010 · HL
Risk Factors for AIDS among Drug Users: Getting Close to Zero
$639,394Don C Des Jarlais · New York University · R01 · FY2019 · DA
Police Training to Reduce Occupational Needlesticks and HIV among Substance Users
$639,375Steffanie A Strathdee · University Of California, San Diego · R01 · FY2017 · DA
UNDERSTANDING HEPATIC PROTEOSTASIS IN SYSTEMIC AMYLOID DISEASES
$639,369Rockland L Wiseman · Scripps Research Institute, The · R01 · FY2020 · DK
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes-Texas Children's Center.
$639,257Fida Bacha · Baylor College Of Medicine · U01 · FY2025 · DK
Functions of vitamin E and the tocopherol transfer protein
$639,192Danny Manor · Case Western Reserve University · R01 · FY2023 · DK
Hepatoprotective Mechanisms of Systemic Bile Acid Transporter Inhibitors
$639,190Paul A Dawson · Emory University · R01 · FY2024 · DK
Hepatocyte FOXA3 in Alcohol-Associated Liver Disease
$639,177Yanqiao Zhang · University Of Arizona · R01 · FY2025 · AA
Improving Contraceptive Effectiveness in Obese Women
$639,146Alison B Edelman · Oregon Health & Science University · R01 · FY2009 · HD
Genetically Programmed Pancreatic Organoids with Self-Adaptive Multi-Lineage Population Control
$639,138Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2025 · HD
Health Consequences Amoung DWI Offenders
$639,126Buffalo State College · R01 · FY2004 · AA
Discovery of Pancreatic Signatures in Type 2 Diabetes Mellitus
$639,010Alvin Carter Powers · Vanderbilt University · R24 · FY2015 · DK
Antigenic structures of HCV envelope glycoproteins (Env)
$639,000Robyn L Stanfield · Scripps Research Institute, The · P01 · FY2022 · AI
Antigenic structures of HCV envelope glycoproteins (Env)
$638,999Robyn L Stanfield · Scripps Research Institute, The · P01 · FY2024 · AI
A PSGL-1 Glycopeptide Mimetic for Treatment of Metabolic Syndrome
$638,976Elliot Chaikof · Beth Israel Deaconess Medical Center · R01 · FY2016 · DK
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance
$638,757Gretchen Lano Birbeck · University Of Rochester · R01 · FY2020 · NS
NorthStar Node of the Clinical Trials Network
$638,706Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2021 · DA
Mechanisms of HBV Functional Cure During Tenofovir-based ART in HIV/HBV Coinfection
$638,647Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · R01 · FY2021 · AI
Rational design and B cell responses of HIV epitope vaccines
$638,644Jiang Zhu · Scripps Research Institute, The · R01 · FY2019 · AI
Rational design and B cell responses of HIV epitope vaccines
$638,644Jiang Zhu · Scripps Research Institute, The · R01 · FY2020 · AI
Rational design and B cell responses of HIV epitope vaccines
$638,644Jiang Zhu · Scripps Research Institute, The · R01 · FY2021 · AI
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis
$638,640Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA